Skip Navigation

ALS News: 2017

field with sun shining

May 11
2017
Breaking Research
The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease
Rea entire press release on www.fda.gov
Apr 13
2017
Packard Center News
A study led by researchers at Stanford University School of Medicine has revealed a possible new therapeutic approach for amyotrophic lateral sclerosis, a progressive neurodegenerative disease.
Read the entire article on www.med.stanford.edu